These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30399303)

  • 1. Taking the initiative in healthcare: Will California voters cap drug prices?
    Castellucci M
    Mod Healthc; 2016 Oct; 46(43):8, 10. PubMed ID: 30399303
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription Drug Pricing Is Not Just an Election Issue.
    Wilensky GR
    Milbank Q; 2016 Dec; 94(4):712-715. PubMed ID: 27995706
    [No Abstract]   [Full Text] [Related]  

  • 3. Developing Prioritization Criteria to Identify Target Drugs for CalRx, the California Generic Drugs Initiative.
    Socal MP; Estus E; Long J; Crane MA; Pegany V; Anderson GF
    Value Health; 2023 May; 26(5):634-638. PubMed ID: 36379412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medication prices in Germany--how are they determined?].
    Bruhn C
    Dtsch Med Wochenschr; 2010 Oct; 135(39):p34. PubMed ID: 20922657
    [No Abstract]   [Full Text] [Related]  

  • 5. Pressure mounts for measures to control drug prices.
    Rice S
    Mod Healthc; 2015 Jul; 45(30):12. PubMed ID: 26510275
    [No Abstract]   [Full Text] [Related]  

  • 6. 'Drug prices are the wrong target'.
    Ubi S; Goozner M
    Mod Healthc; 2016 May; 46(18):30-1. PubMed ID: 27363104
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug Imports: The New Idea That's Kind of Old.
    Kirkner RM
    Manag Care; 2016 May; 25(5):12-3. PubMed ID: 27351059
    [No Abstract]   [Full Text] [Related]  

  • 8. The ACA-and other healthcare issues confronting a new Congress.
    Wilensky GR
    Healthc Financ Manage; 2017 Jan; 71(1):28-9. PubMed ID: 29901368
    [No Abstract]   [Full Text] [Related]  

  • 9. Why Congress must deal with drug prices.
    Goozner M
    Mod Healthc; 2015 Dec; 45(50):24. PubMed ID: 26875325
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drug prices in the US.
    Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697
    [No Abstract]   [Full Text] [Related]  

  • 11. Separation of prescription and treatment in health care markets: A laboratory experiment.
    Greiner B; Zhang L; Tang C
    Health Econ; 2017 Dec; 26 Suppl 3():21-35. PubMed ID: 29285866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555
    [No Abstract]   [Full Text] [Related]  

  • 13. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
    Sarpatwari A; Avorn J; Kesselheim AS
    JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027
    [No Abstract]   [Full Text] [Related]  

  • 14. Determinants of branded prescription medicine prices in OECD countries.
    Kanavos PG; Vandoros S
    Health Econ Policy Law; 2011 Jul; 6(3):337-67. PubMed ID: 21676345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plenty of green in gray market. There's more at issue than just inflated prices for drugs in short supply.
    May D
    Mod Healthc; 2011 Oct; 41(42):25. PubMed ID: 22049782
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015.
    Rosenberg ME; Rosenberg SP
    JAMA Dermatol; 2016 Feb; 152(2):158-63. PubMed ID: 26606197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How insurers' bargaining power affects drug prices in Medicare Part D.
    Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274
    [No Abstract]   [Full Text] [Related]  

  • 18. The redesign of consumer cost sharing for specialty drugs at the California Health Insurance Exchange.
    Robinson J; Price A; Goldman Z
    Am J Manag Care; 2016 Mar; 22(4 Suppl):s87-91. PubMed ID: 27270158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commercial importation of prescription drugs in the United States: short-run implications.
    Danzon PM; Johnson SJ; Long G; Furukawa MF
    J Health Polit Policy Law; 2011 Apr; 36(2):295-316. PubMed ID: 21543707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Availability and variation of publicly reported prescription drug prices.
    Kullgren JT; Segel JE; Peterson TA; Fendrick AM; Singh S
    Am J Manag Care; 2017 Jul; 23(7):444-448. PubMed ID: 28817781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.